U.S. Stock News

Cooling inflation in June, renewed tension in oil markets, and a cautious Federal Reserve have created a mixed backdrop for consumer discretionary stocks. Lower headline CPI and reduced pressure for immediate rate hikes can support household budgets, while higher energy prices and the possibility of later rate increases keep uncertainty high. In this environment, a group of large consumer companies with stronger past and expected performance metrics stand out for closer review. This article...

Simon Property Group recently updated investors that it is set to release its second-quarter results, alongside raising its full-year 2026 Real Estate FFO guidance after a period of consistent earnings outperformance versus analyst expectations. This combination of an upcoming results catalyst and higher full-year guidance sharpens attention on how reliably the REIT is translating operating trends into cash flow. We’ll now examine how Simon Property Group’s raised full-year Real Estate FFO...

Recent Performance Context for Jazz Pharmaceuticals Stock Jazz Pharmaceuticals (JAZZ) has drawn investor attention after a period of strong longer term returns, with the stock showing gains over the past year and past 3 years, alongside positive revenue and net income growth. See our latest analysis for Jazz Pharmaceuticals. At a share price of $238.05, Jazz Pharmaceuticals has had a 90 day share price return of 19.43% and a year to date share price return of 37.48%. The 1 year total...

BioCryst Pharmaceuticals stock has rebounded in recent years but is still down about 40.0% over five years, which sits alongside valuation checks that currently lean cheap on traditional metrics. With recent news highlighting both a shift toward external innovation and takeover speculation, investors are trying to work out whether the recent strength in the share price is backed by the fundamentals or running ahead of them. The share price decline of about 40.0% over five years leaves long...

Krystal Biotech’s stock has delivered a very large 439.7% return over the past five years, yet its current checks lean expensive, with a low value score and the market multiples suggesting investors are paying a premium for that track record. Over five years, shareholders have seen a 439.7% return, which puts extra focus on whether today’s price still reflects a reasonable entry point. Expectations for Krystal Biotech’s future revenue and cash flow can support a premium valuation, but any...

SkyWest stock has delivered a strong 5 year return, yet after a recent analyst downgrade and a weaker 1 year share price performance, the valuation checks still lean toward the shares looking inexpensive rather than fully priced. SkyWest has returned 144.0% over the past 5 years, which puts the current debate squarely on whether the long run share price gains already reflect what the business can deliver. The appointment of Wade Steel as president and chief operating officer may support...

CleanSpark (NasdaqCM:CLSK) signed a 20-year triple net infrastructure lease with a leading global technology company at its Sandersville, Georgia campus. The agreement focuses on high performance computing infrastructure and extends beyond CleanSpark’s core bitcoin mining activities. A letter of intent covers the company’s entire Texas power portfolio, pointing to expanded use of those assets under long-term contracts. CleanSpark has been best known as a bitcoin mining company, but this new...

United Airlines Holdings (NasdaqGS:UAL) has introduced a new Economy Plus concept for its upcoming Airbus A321XLR aircraft. The design uses open middle seats to create extra space and shared tables, which the company describes as a first for U.S. airlines. This cabin layout is planned for international routes where longer flight times can make seating comfort more important for passengers. United Airlines is a major U.S. carrier with a global network, and its Economy Plus product is a key...

Element Solutions stock has more than doubled investors' money over the past three years, yet its valuation sends mixed signals, with a Discounted Cash Flow (DCF) estimate pointing to roughly 10.1% upside to intrinsic value while market multiples lean the other way and suggest the shares are not cheap. The proposed Solstice Advanced Materials deal adds another layer, because the implied offer value sits above the recent US$40.65 close and invites questions about how the market is pricing the...

PriceSmart, Inc. has already reported its third-quarter and nine-month results to May 31, 2026, with revenue rising to US$1,481.79 million and US$4,360.05 million respectively, alongside net income of US$39.69 million for the quarter and US$128.95 million for the nine-month period. The improvement in basic earnings per share from continuing operations, to US$1.28 for the quarter and US$4.19 for the nine months, highlights how recent performance compares with the prior year and may influence...

MSIG Europe Expands Use of Clearwater Platform Clearwater Analytics Holdings (CWAN) drew fresh attention after MSIG Europe selected its platform to modernize investment operations, unify data across the investment lifecycle, and address European regulatory requirements. This new mandate follows prior deployments at MSIG’s Asia office and other business units, giving Clearwater Analytics additional exposure to the insurance sector and a broader foothold in European markets. See our latest...

With Fed Chair Kevin Warsh signaling that interest rates may stay higher for longer, inflation still above the 2% target, and oil prices jumping after renewed tensions in the Strait of Hormuz, many investors are reassessing how reliable their income stocks really are. Dividend Aristocrats, with long records of raising payouts and a focus on financial discipline, can look appealing when volatility and inflation risks rise together. This article walks through 3 stocks from our Dividend...

With markets on edge over energy shocks, inflation data and shifting rate expectations, many investors are looking for companies where insiders have meaningful skin in the game and where growth expectations remain optimistic. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that combination, highlighting businesses where management and analysts both see room for expansion and leaders are heavily invested alongside you. This article introduces three stocks from...

American Financial Group, NYSE:AFG, is drawing attention for slower growth in net premiums earned relative to insurance peers. Earnings per share growth has been modest, while book value per share has declined compared with other insurers. These trends are prompting closer scrutiny of the company’s fundamentals and positioning within the insurance sector. American Financial Group, NYSE:AFG, is coming under closer review as recent data shows slower growth in key operating metrics than many...

ScanSource, Inc. recently announced an expanded partnership with HPE that now includes HPE Juniper Networking, broadening its networking, cybersecurity and AI-native enterprise solutions for channel partners and end users. A key feature of the announcement is the use of ScanSource Launch Point to accelerate HPE’s go-to-market efforts with tailored channel programs and new routes to market. We’ll now examine how this deeper HPE relationship, particularly the Launch Point go-to-market support,...

Rubrik stock has climbed about 23% over the past month. However, the latest valuation checks suggest it no longer stands out as a clear bargain, with the Discounted Cash Flow (DCF) intrinsic value estimate sitting close to, rather than far from, the current share price. Rubrik's roughly 23% gain in the past month highlights strong recent momentum that may already reflect a lot of optimism in the price. Recent announcements around AI driven security offerings and a sizeable UK investment can...

Insight Holdings Group has significantly reduced its stake in Hinge Health (NYSE:HNGE) after a period of revenue growth and improved guidance. The move follows reported efficiency gains from AI automation across Hinge Health's operations. The share sale comes with Hinge Health trading at a current share price of $90.0. Hinge Health sits in the spotlight as one of the more closely watched digital health stocks, with the share price at $90.0 and returns of 37.7% over the past 30 days and...

Insulet (NasdaqGS:PODD) has announced a global partnership with Calm to introduce mental health and mindfulness support tailored for people with diabetes and their caregivers. The collaboration creates a first-of-its-kind MedTech and mental health content collection integrated around diabetes care. The program is expected to roll out globally, supported by high-profile advocates from the diabetes community. Insulet, trading at $162.06, is widely recognized for its insulin delivery...

EquipmentShare.com (EQPT) has drawn fresh investor attention after raising its 2026 revenue outlook to a range of $5,254 million to $5,682 million and unveiling a new $500 million share repurchase program. See our latest analysis for EquipmentShare.com. Despite the raised 2026 revenue guidance and the new buyback authorization, EquipmentShare.com’s 1 day share price return declined 9.79%, contributing to a year to date share price return that is down 48.33% and signaling fading momentum in...

Blue Owl Capital’s share price has fallen 48.2% over the past year, yet the stock still screens as expensive on broad valuation checks, which raises a clear question about how much downside risk the current valuation still carries. Over the most recent 1 year window, Blue Owl Capital is down 48.2%, which means recent shareholders have worn a heavy drawdown that is front of mind when thinking about valuation risk. While acquisitions in healthcare real estate and digital infrastructure can...

Inflation is getting pulled in different directions right now, with energy swings, higher services costs, tech demand, and war driven spending all feeding into the same story. That mix can be uncomfortable for markets, but it can also create clear winners and losers as pricing power, cost control, and business models are put to the test. This article looks at 3 service sector stocks from our screener that appear closely tied to these trends and explains how the recent news could affect them...

Nucor’s share price has delivered a strong 178.7% total return over the past 5 years, while its current valuation signals indicate that the stock still screens as undervalued on both intrinsic value estimates and market multiples. A 178.7% return over 5 years suggests Nucor has already rewarded patient shareholders. Any further potential upside now matters more for new investors weighing entry price against risk. Expectations for Nucor’s future cash generation can support the current...

The United States market has remained flat over the last week, yet it is up 19% over the past year with earnings expected to grow by 18% per annum in the coming years. In this context, identifying stocks that are trading below their intrinsic value can be a strategic move for investors seeking potential opportunities amidst steady market conditions.

In the last week, the United States market has stayed flat but it is up 19% over the past year with earnings forecasted to grow by 18% annually. In such a promising environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.